REFERENCES
- Fischman MW, Johanson CE. Ethical and practical issues involved in behavioral pharmacology research that administers drugs of abuse to human volunteers. Behav Pharmacol 1998; 9(7):479–498. [INFOTRIEVE], [CSA]
- Nahas GG. The experimental use of cocaine in human subjects. Bulletin on Narcotics 1990; 42(1):57–62. [INFOTRIEVE], [CSA]
- Mendelson JH. Protection of participants and experimental design in clinical abuse liability testing. British Journal of Addiction 1991; 86(12):1543–1548. [INFOTRIEVE], [CSA], [CROSSREF]
- Modell JG, Glaser FB, Mountz JM. The ethics and safety of alcohol administration in the experimental setting to individuals who have chronic, severe alcohol problems. Alcohol & Alcoholism 1993; 28(2):189–197. [INFOTRIEVE], [CSA]
- Elman I, Krause S, Karlsgodt K, Schoenfeld DA, Gollub RL, Breiter HC, Gastfriend DR. Clinical outcomes following cocaine infusion in nontreatment-seeking individuals with cocaine dependence. Biological Psychiatry 2001; 49(6):553–555. [INFOTRIEVE], [CSA], [CROSSREF]
- Bigelow GE, Brooner RK, Walsh SL, Preston KL, Liebson IA. Community outcomes following research exposure to cocaine or opioids. NIDA Monographs 1994; 153:354. [CSA]
- Hajak G, Muller WE, Wittchen HU, Pittrow D, Kirch W. Abuse and dependence potential for the non-benzodiazepine hypnotics zolpidem and zopiclone: A review of case reports and epidemiological data. Addiction 2003; 98(10):1371–1378. [INFOTRIEVE], [CSA], [CROSSREF]
- Madrak LN, Rosenberg M. Zolpidem abuse. American Journal of Psychiatry 2001; 158(8):1330–1331. [INFOTRIEVE], [CSA], [CROSSREF]
- Rush CR, Baker RW, Wright K. Acute behavioral effects and abuse potential of trazodone, zolpidem and triazolam in humans. Psychopharmacology 1999; 144(3):220–233. [INFOTRIEVE], [CSA], [CROSSREF]
- Foltin RW, Haney M, Comer SD, Fischman MW. Effect of fluoxetine on food intake of humans living in a residential laboratory. Appetite 1996; 27(2):165–181. [INFOTRIEVE], [CSA], [CROSSREF]
- Haney M, Hart CL, Vosburg SK, Nasser J, Bennett A, Zubaran C, Foltin RW. Marijuana withdrawal in humans: Effects of oral THC or divalproex. Neuropsychopharmacology 2004; 29(1):158–170. [INFOTRIEVE], [CSA], [CROSSREF]
- Haney M, Hart CL, Ward AS, Foltin RW. Nefazodone decreases anxiety during marijuana withdrawal in humans. Psychopharmacology 2003; 165(2):157–165. [INFOTRIEVE], [CSA]
- Hart CL, Haney M, Ward AS, Fischman MW, Foltin RW. Effects of oral THC maintenance on smoked marijuana self-administration. Drug Alcohol Depend 2002; 67(3):301–309. [INFOTRIEVE], [CSA], [CROSSREF]
- Hart CL, Ward AS, Haney M, Foltin RW, Fischman MW. Methamphetamine self-administration by humans. Psychopharmacology (Berl) 2001; 157(1):75–81. [CSA], [CROSSREF]
- Hart CL, Ward AS, Haney M, Foltin RW. Zolpidem-related effects on performance and mood during simulated night-shift work. Experimental & Clinical Psychopharmacology 2003; 11(4):259–268. [INFOTRIEVE], [CSA], [CROSSREF]
- McLellan AT, Luborsky L, Woody GE, O'Brien CP. An improved diagnostic evaluation instrument for substance abuse patients. The addiction severity index. Journal of Nervous & Mental Disease 1980; 168(1):26–33. [INFOTRIEVE], [CSA]